Keywords: pvs-10200, increases, lumen, area, pad, pervasis, therapeutics

PVS-10200 increases lumen area in PAD

Article | 03 June 2009

Pervasis Therapeutics, a US biotechnology firm focused on active cellular therapies, reported strong new preclinical data for PVS-10200, a minimally-invasive ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Amino Acids

Injection

Physostigmine Salicylate

Go to drug listing